Funding Received
$35.3 Million in 2 Rounds from 5 Investors
Most Recent Funding
$25.7 Million Series B on November 4, 2013
Founded:
July, 2011
Headquarters:
Vienna
Description:
Hookipa Biotech develops prophylactic and therapeutic vaccines for the prevention and treatment of multiple infectious diseases and cancer.
Categories:
Biotechnology
Website:
http://hookipabiotech.com

Detailed Description

Update

Hookipa Biotech, a startup biotech company specialized in developing new generation vaccines. Founded in July 2011, in Austria, Hookipa Biotech has developed a proprietary technology platform, VaxwaveTM, dedicated to genetic vaccines for the prophylactic and therapeutic treatment of viral diseases. VaxwaveTM introduces a new approach to vaccination by providing long lasting and potent stimulation of both cellular and humoral immunity; the platform has been validated in different disease models. The company will use the Series A funds to advance its lead product HB101 through pre-clinical development and a Phase I proof of concept study, and to further industrialize and validate the VaxwaveTM technology.

Current Team (3)

Update

Past Team (1)

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Office

    Helmut-Qualtinger-Gasse 2

    Vienna, 1030

    AUT

Images (1)

Update
  • Ecf1a032fc2500da8b14555ddfc548a4